Financhill
Back

Columbia Research Enhanced Value ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
76

REVS
Columbia Research Enhanced Value ETF

Last Price:
$29.13
Seasonality Move:
1.74%
Sell
45

ZBIO
Zenas BioPharma, Inc.

Last Price:
$35.81
Seasonality Move:
-8.13%
Buy
76
Columbia Research Enhanced Value ETF (REVS) is a Buy

Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Value ETF [REVS] share price is $28.93. The Score for REVS is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • REVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $36.89. The Score for ZBIO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REVS Stock Price Chart

What is Columbia Research Enhanced Value ETF's stock price today?

  • The Columbia Research Enhanced Value ETF share price today is $28.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing slight selling pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $36.89
    The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

REVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 57.83 Buy
Chaikin Money Flow: -1781 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 51.69 Buy
Chaikin Money Flow: 321584 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

REVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.96 Sell
20-day SMA: 28.47 Buy
50-day SMA: 28.18 Buy
200-day SMA: 26.5 Buy
8-day EMA: 28.94 Sell
20-day EMA: 28.63 Buy
50-day EMA: 27.73 Buy
200-day EMA: 17.47 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.29 Sell
20-day SMA: 37.71 Sell
50-day SMA: 32.54 Buy
200-day SMA: 17.6 Buy
8-day EMA: 37.45 Sell
20-day EMA: 34.56 Buy
50-day EMA: 23.69 Buy
200-day EMA: 8.26 Buy

Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Columbia Research Enhanced Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):